Global Hemoglobin A1c Monitoring Industry
Graph/Chart) II-30
Therapeutic Options for Diabetes II-31
Oral Medication for Type 2 Diabetes II-31
Side Effects of Insulin Therapy II-32
Side Effects II-32 Maintaining A1c Test Result Below 7% II-32 Common Diabetes Management Practices II-32 4. PRODUCT APPROVALS/INTRODUCTIONS II-33 EKF Obtains CE Mark for Quo-Lab POC HbA1c Analyser II-33 Streck Launches A1c-Cellular Linearity Verification Material II-33 Abbott Obtains CE Marking for ARCHITECT HbA1c (IA) Fully Automated Assay II-34 Trinity Obtains FDA Approval for Premier Hb9210 HbA1c Device II-34 Siemens Launches Fortified Version of DCA Vantage Analyzer II-35 Tosoh Launches New Assay on its AIA-600II and AIA-360 Analyzers II-35 Siemens Unveils ADVIA® Chemistry HbA1c Assay II-36 Bayer Healthcare Introduces A1CNow® SELFCHECK II-36 Randox Introduces HbA1c Test II-36 Animas Obtains FDA Approval for OneTouch Glucose Management System II-36 ARKRAY USA Obtains FDA Approval for GLUCOCARD II-37 Bayer's Breeze Blood Glucose Monitoring System Receives Commendation II-37 Quantimetrix Develops GlycoHemosure II-37 Olympus Life Science Europa Unveils HbA1c assay II-38 Siemens Healthcare Introduces DCA Vantage™ Analyser II-38 5. RECENT INDUSTRY ACTIVITY II-39 Trinity Inks Distribution Agreement with Menarini for Premier Hb9210 II-39 Danaher Acquires Beckman Coulter II-39 Geonostics Takes Over Consumer Diabetes Tests of FlexSite II-39 EKF Diagnostics Takes Over Quotient Diagnostics II-39 ADA Recommends HbA1c Lab Test for Identification of Pre-Diabetes II-40 HemoCue and MEC Dynamics Inks Distribution Agreement for Avie A1c POC Test II-40 Trinity Biotech Submits TRIstat™ CLIA Application to FDA II-40 Arkray Partners with Elitech to Supply In-vitro Diagnostic Systems II-41 Quest Diagnostics Receives Accreditation from NABL and CAP II-41 Quest Diagnostics Achieves Accreditation for its Laboratory in India II-41 PPD Inks an Agreement with PUL to Expand Lab Services into China II-42 Roche Inks Marketing Agreement with Mankind Pharma II-42 Nicholas Piramal Forms Joint Venture with Arkray II-42 Quotient Diagnostics to Commence Production of Quo-Test System II-42 Pelikan and Eli Lilly Sign Co-Promotion Agreement II-43Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
